LESTER E. WOLD, M.D.
The purpose of this presentation is to report a complication observed while giving histamine intra-arterially in the treatment of peripheral vascular disease. The treatment of obliterative arterial disease described by Mufson1 has a definite appeal because it may be done as an office procedure. Before this method of therapy was suggested, there was little that could be offered the patient with obliterative arterial disease except in larger centers where long periods of treatment on Saunder's bed, sympathectomy, or physical therapy could be given. Such regimes of therapy are frequently so costly as to be beyond the reach of many patients
WOLD LE. TRAUMATIC THROMBOPHLEBITIS DURING INTRA-ARTERIAL HISTAMINE THERAPY(TRAUMATIC THROMBOPHLEBITIS DURING INTRA-ARTERIAL HISTAMINE THERAPY*). Ann Intern Med. 1950;32:987–988. doi: 10.7326/0003-4819-32-5-987
Download citation file:
Published: Ann Intern Med. 1950;32(5):987-988.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use